Standard Operating Procedure for Handling Packing Line Discrepancies

1. Purpose

To provide a standard procedure for the identification, investigation, documentation, and resolution of discrepancies encountered during packing operations in the sterile injectable manufacturing area. This ensures product integrity, traceability, and compliance with GMP requirements.

2. Scope

This SOP applies to all packaging lines and related operations involving the packing of sterile injectable products, including vials, ampoules, and prefilled syringes in the sterile injection manufacturing department.

3. Responsibilities

• Production Operator: Identify and report discrepancies immediately to the supervisor.
• Packing Supervisor: Verify discrepancies, initiate investigation, and coordinate corrective action.
• Quality Assurance (QA): Evaluate the impact of discrepancies, assist in investigation, and authorize product disposition.
• Quality Control (QC): Support analytical testing if needed during discrepancy resolution.
• Engineering/Maintenance: Investigate mechanical failures contributing to discrepancies.

4. Accountability

The Head of Production is accountable for ensuring the implementation of this SOP and addressing packing line discrepancies in coordination with QA.

5. Procedure

5.1 Identification of Discrepancies

1. Discrepancies may include:
   • Incorrect labeling or missing labels
   • Unsealed or partially sealed units
   • Wrong batch number or expiry date
   • Mixed product batches
   • Incorrect quantity packed
   • Carton damage or missing leaflets
2. Operators must immediately report any observed discrepancy to the supervisor.

5.2 Initial Action

1. The supervisor shall:
   • Stop the line if necessary
   • Quarantine affected units
   • Notify QA for further assessment

5.3 Documentation and Verification

1. Document the discrepancy in the Packing Line Discrepancy Log (Annexure-1).
2. QA will inspect the quarantined units and surrounding area.
3. Conduct reconciliation of labels, cartons, leaflets, and units packed to detect any mismatch.
4. Record details such as product name, batch number, nature of discrepancy, quantity affected, and date/time observed.

5.4 Investigation and Root Cause Analysis

1. QA and Production shall jointly perform a root cause analysis using tools like:
   • Fishbone (Ishikawa) diagram
   • 5 Whys technique
2. If necessary, Engineering shall be involved to assess equipment malfunction.
3. Capture investigation results in the Discrepancy Investigation Report (Annexure-2).

5.5 Corrective and Preventive Action (CAPA)

1. Based on investigation outcome, QA shall recommend CAPA.
2. Implement corrective measures immediately and document them.
3. Preventive actions may include:
   • Operator training
   • Label redesign
   • Equipment calibration or maintenance
4. Record CAPA actions in Annexure-3: CAPA Log.

5.6 Disposition and Line Clearance

1. Only QA may approve product rework, rejection, or release.
2. Line clearance shall be re-performed after resolving the discrepancy before resuming packing.

5.7 Documentation and Record Retention

1. Maintain completed records of discrepancy logs, investigation reports, and CAPA logs.
2. Store documents securely for a minimum of 5 years from batch release date.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• QC: Quality Control
• CAPA: Corrective and Preventive Action
• GMP: Good Manufacturing Practice

7. Documents

1. Packing Line Discrepancy Log – Annexure-1
2. Discrepancy Investigation Report – Annexure-2
3. CAPA Log – Annexure-3

8. References

• WHO TRS 986 Annex 2 – GMP Guidelines for Pharmaceutical Products
• ICH Q10 – Pharmaceutical Quality System
• 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Packing Line Discrepancy Log

Annexure-2: Discrepancy Investigation Report

Annexure-3: CAPA Log

Revision History

Standard Operating Procedure for Documentation of Packaging Line Performance

1. Purpose

This SOP defines the standard process for documentation of packaging line performance in the Sterile Injection Manufacturing department. It ensures compliance with GMP, supports traceability of operations, and aids in evaluating efficiency and identifying areas of improvement.

2. Scope

This procedure applies to all sterile injectable packaging lines, including vial packing, ampoule packing, prefilled syringe lines, and automated or semi-automated systems operated at the facility.

3. Responsibilities

• Packaging Operator: Records line parameters and output in real time.
• Line Supervisor: Reviews and verifies records and ensures any deviations are reported immediately.
• QA Executive: Audits documentation, verifies compliance, and reviews trends for continuous improvement.

4. Accountability

The Head of Production and Head of Quality Assurance are accountable for ensuring the documentation process is implemented and followed as per this SOP.

5. Procedure

5.1 Initiation of Packaging Activity

1. Prior to line startup, ensure that line clearance has been completed and documented as per SOP/SIM/191/2025.
2. Verify availability of approved batch packaging record (BPR) and approved labels.
3. Start the packaging line under supervision, recording the start time and initial observations.

5.2 Real-Time Recording of Performance Parameters

1. Use the Packaging Line Performance Log (Annexure-1) to record the following:
   • Line Start and Stop Times
   • Shifts and Operator Names
   • Machine Speeds and Output per Hour
   • Downtime (with reasons)
   • Rejected Units (categorized by cause)
2. Ensure all entries are made in real-time using indelible ink. Do not leave blank spaces.

5.3 Shift Handover Documentation

1. At the end of each shift, the outgoing operator must brief the incoming operator and sign the handover section in the logbook.
2. Any unresolved issues must be clearly documented and highlighted to the supervisor.

5.4 Recording Deviations and Incidents

1. Any deviations from standard packaging line operations (e.g., frequent rejections, unplanned stoppages) must be recorded in the deviation section of the logbook.
2. QA must be notified immediately for evaluation and impact assessment.
3. Complete a Deviation Form (Annexure-2) if applicable.

5.5 Verification of Line Performance

1. Line Supervisor shall verify the log entries every 4 hours and sign-off on completed pages.
2. QA Executive shall conduct end-of-day review to confirm that data is complete, legible, and compliant.

5.6 Compilation and Archiving

1. At batch completion, line performance data shall be compiled and attached to the BPR.
2. All original logbooks must be retained in QA archives for a minimum of 5 years.

5.7 Training and Review

1. All packaging line personnel shall be trained on this SOP annually.
2. Training records to be maintained as per Annexure-3.

6. Abbreviations

• SOP: Standard Operating Procedure
• BPR: Batch Packaging Record
• QA: Quality Assurance
• GMP: Good Manufacturing Practice

7. Documents

1. Packaging Line Performance Log – Annexure-1
2. Deviation Reporting Form – Annexure-2
3. Training Attendance Record – Annexure-3

8. References

• WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
• EU GMP Annex 15 – Qualification and Validation
• 21 CFR Part 211 – Current Good Manufacturing Practice

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Packaging Line Performance Log

Annexure-2: Deviation Reporting Form

Annexure-3: Training Attendance Record

Revision History:

Standard Operating Procedure for Ensuring Tamper-Evident Sealing on Syringe Packs

1. Purpose

To establish a consistent and GMP-compliant procedure for ensuring tamper-evident sealing on syringe packs in order to prevent unauthorized access or contamination, maintain product integrity, and comply with regulatory expectations for injectable packaging.

2. Scope

This SOP is applicable to all tamper-evident sealing processes of prefilled syringes during the secondary packaging operations at the Sterile Injection Manufacturing facility.

3. Responsibilities

• Packing Operator: Ensures correct application of tamper-evident seals during packaging.
• Line Supervisor: Verifies sealing operation and inspects sealing integrity.
• Quality Assurance (QA): Conducts in-process checks and documents compliance.
• Engineering: Maintains and calibrates sealing machines.

4. Accountability

The Head of Production is accountable for the implementation and compliance of this SOP. The Head of QA is accountable for final approval and audit readiness.

5. Procedure

5.1 Receiving and Preliminary Inspection

1. Receive tamper-evident labels or seals from the warehouse with accompanying CoA.
2. Check packaging materials for integrity, batch number, and expiry date.
3. Document receipt in the Tamper Seal Logbook (Annexure-1).

5.2 Verification of Sealing Materials

1. Verify that the tamper-evident seals match the approved artwork and specifications.
2. Cross-check the delivery against the packing batch record and Bill of Materials.
3. Ensure materials are released by QA before usage.

5.3 Machine Setup and Trial Run

1. Set sealing machine parameters as per validated batch protocol.
2. Perform a trial run of 10 units; inspect for alignment, adhesion, and legibility.
3. Get QA clearance for commencing full operation.

5.4 Tamper-Evident Sealing Process

1. Feed prefilled syringe packs into the automated sealing machine.
2. Ensure continuous monitoring of label roll placement and adhesive temperature.
3. Monitor critical parameters such as pressure, dwell time, and seal width.
4. Replace label rolls immediately upon detecting end-of-roll or misalignment.

5.5 In-Process Inspection

1. Inspect one unit every 15 minutes for seal placement, tamper visibility, and legibility.
2. Use a standard checklist (Annexure-2) to document visual checks.
3. In case of deviation, isolate affected units and notify QA.

5.6 Post-Operation Verification

1. Ensure all packs in the batch are sealed and intact before transferring to the shipper.
2. Document reconciliation of tamper seals used versus dispensed in Annexure-3.
3. Affix line clearance label and have it verified by QA.

5.7 Documentation and Record-Keeping

1. Maintain the Tamper Seal Logbook (Annexure-1).
2. Attach in-process inspection records and reconciliation sheets with the BPR.
3. QA shall review and archive records for traceability.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• CoA: Certificate of Analysis
• BPR: Batch Packing Record

7. Documents

1. Tamper Seal Logbook – Annexure-1
2. Visual Inspection Checklist – Annexure-2
3. Seal Reconciliation Sheet – Annexure-3

8. References

• WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
• 21 CFR Part 211 – Current Good Manufacturing Practice
• ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Tamper Seal Logbook

Annexure-2: Visual Inspection Checklist

Annexure-3: Seal Reconciliation Sheet

Revision History:

Standard Operating Procedure for Packaging of Temperature-Sensitive Injectable Products

1. Purpose

To define the procedure for the proper packaging of temperature-sensitive injectable products to ensure the integrity, efficacy, and compliance of the finished products with regulatory standards during storage, handling, and transportation.

2. Scope

This SOP applies to all temperature-sensitive injectable products manufactured in the Sterile Injection Manufacturing department, including vials, ampoules, and prefilled syringes that require controlled temperature conditions during secondary and tertiary packaging.

3. Responsibilities

• Packaging Operators: Execute the packaging activity as per the SOP.
• QA Personnel: Verify temperature-sensitive packaging compliance and approve batch for dispatch.
• Warehouse Staff: Provide validated packaging materials and manage cold storage logistics.
• Engineering Team: Ensure temperature monitoring systems in packaging and storage areas are functional.

4. Accountability

The Head of Production and Head of Quality Assurance are accountable for ensuring adherence to this SOP and for maintaining packaging conditions suitable for temperature-sensitive injectable products.

5. Procedure

5.1 Preparation and Verification of Packaging Materials

1. Obtain the list of temperature-sensitive products to be packed from the production planner or batch processing record (BPR).
2. Ensure all secondary and tertiary packaging materials (insulated shippers, gel packs, thermal indicators) are available and validated for the specified temperature range (e.g., 2–8°C).
3. Check the calibration status of temperature monitoring devices (e.g., data loggers, IR thermometers).

5.2 Conditioning and Pre-Assembly

1. Precondition insulated shippers and gel packs as per vendor instructions or validation protocol.
2. Verify that conditioned materials are maintained within the required range before use.
3. Set up the packaging area within a temperature-controlled zone (if applicable) or monitor ambient temperature during the operation.

5.3 Packaging Process

1. Transfer labeled, packed primary units from cold room or refrigerated area to packaging area using validated cold boxes.
2. Insert temperature indicators or data loggers in each shipping unit as per the SOP.
3. Layer the secondary and tertiary components:
   • Line the insulated shipper with gel packs as per validated layout.
   • Place injectable units in sterile polybags or trays.
   • Insert product leaflet and label correctly.
   • Seal the shipper and apply external shipping label with temperature sensitivity warning.

5.4 Labeling and Documentation

1. Ensure that each package label includes:
   • Product name and strength
   • Batch number
   • Storage temperature range (e.g., “Store between 2°C and 8°C”)
   • Shipping and handling instructions
2. Record packaging details in the Temperature-Sensitive Packaging Log (Annexure-1).

5.5 Final QA Review and Release

1. QA shall:
   • Verify packaging against approved checklist
   • Confirm data logger configuration and functionality
   • Approve the release of final packed units

5.6 Transportation Coordination

1. Coordinate with the dispatch team and logistics provider to ensure cold chain continuity.
2. Review transportation SOP and instruct the carrier on necessary precautions.

5.7 Deviations and Corrective Actions

1. Record any observed temperature excursions in the deviation register.
2. Initiate CAPA and document findings in the deviation form (Annexure-2).

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• BPR: Batch Processing Record
• CAPA: Corrective and Preventive Action

7. Documents

1. Temperature-Sensitive Packaging Log – Annexure-1
2. Deviation Form – Annexure-2

8. References

• WHO Technical Report Series 961 – Annex 9: Model Guidance for the Storage and Transport of Time- and Temperature–Sensitive Pharmaceutical Products
• ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Temperature-Sensitive Packaging Log

Annexure-2: Deviation Form

Revision History:

Standard Operating Procedure for Inspection of Cartons Used for Injectable Packing

1. Purpose

To establish a standardized procedure for the inspection of cartons used in the packing of sterile injectable products. This SOP ensures all secondary packaging cartons meet the predefined quality, dimensional, and label verification criteria prior to use.

2. Scope

This SOP applies to all visual, dimensional, and quality inspections of printed and unprinted cartons used in packing operations for injectable products within the sterile injection manufacturing facility.

3. Responsibilities

• QA Executive: To perform and document quality inspection of cartons before batch release.
• Packing Operator: To segregate, present, and verify cartons before and during packing operations.
• Warehouse Personnel: To deliver cartons with associated documentation such as approved labels and CoA.
• QC Analyst: To assist in material sampling and testing when required.

4. Accountability

The Head of Quality Assurance is accountable for ensuring compliance with this SOP and release of only inspected and approved cartons for injectable product packing.

5. Procedure

5.1 Receiving and Preliminary Inspection

1. Upon receiving cartons in the packing area, verify that the delivery is accompanied by an approved Certificate of Analysis (Annexure-2) and label artwork.
2. Check for transport damages such as torn cartons, water damage, or misaligned flaps.
3. Ensure batch number, product name, and version code match with the packing order.

5.2 Dimensional and Physical Verification

1. Measure the external dimensions of the cartons (length, width, height) using calibrated vernier calipers or templates.
2. Check GSM (grams per square meter) and ply quality if applicable.
3. Verify slot alignments, scoring depth, and folding strength as per packaging design specifications.
4. Record results in the Carton Inspection Log (Annexure-1).

5.3 Printing and Label Inspection

1. Visually inspect 5 cartons per batch or per 1000 cartons (whichever is greater) for:
   • Clarity of print
   • Proper label placement
   • Correct font and batch data matrix/barcode printing
   • Absence of smudging, misprints, or offset text
2. Perform barcode verification using a barcode scanner.

5.4 Sampling for Testing

1. If needed, send representative carton samples to the QC lab for:
   • GSM verification
   • Compression strength testing
2. Document sampling in the QC Sample Log.

5.5 Label and Artwork Verification

1. Compare the printed label and artwork with the approved version stored in the QA Master File.
2. Ensure the carton batch code and item code match the packing batch.

5.6 Documentation and Approval

1. Fill out the Carton Inspection Log (Annexure-1).
2. Attach supporting CoA and artwork copies (Annexure-2).
3. Submit for QA review and approval via Carton Approval Form (Annexure-3).
4. Approved cartons may be released to the packing area and labeled as “APPROVED.”

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• QC: Quality Control
• GSM: Grams per Square Meter
• CoA: Certificate of Analysis

7. Documents

1. Carton Inspection Log – Annexure-1
2. Certificate of Analysis – Annexure-2
3. Carton Approval Form – Annexure-3

8. References

• GMP Guidelines – Schedule M
• ICH Q10 – Pharmaceutical Quality System
• WHO Guidelines on Packaging Material Control

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Carton Inspection Log

Annexure-2: Certificate of Analysis (Cartons)

Annexure-3: Carton Approval Form

Revision History

Standard Operating Procedure for Sealing Quality Testing during Packing

1. Purpose

To establish a standardized procedure for performing sealing quality tests during packing operations of sterile injectable products to ensure proper container closure integrity and compliance with GMP guidelines.

2. Scope

This SOP applies to all visual and mechanical sealing quality tests conducted during the secondary and tertiary packing of injectable vials, ampoules, and prefilled syringes within the sterile injection manufacturing facility.

3. Responsibilities

• Packing Operator: Conducts sealing tests as per the procedure and records results.
• Quality Assurance Officer: Verifies adherence to sealing quality criteria and reviews documentation.
• Packing Supervisor: Ensures operators are trained and SOP compliance is maintained.

4. Accountability

The Head of Quality Assurance is accountable for ensuring proper implementation of this SOP and for verifying compliance with applicable sealing integrity requirements.

5. Procedure

5.1 Sampling and Frequency

1. Perform sealing quality tests at the start of batch, after every changeover, and at predefined intervals (e.g., every 30 minutes).
2. Sample quantity:
   • Vials: 10 per sampling point
   • Ampoules: 10 per sampling point
   • Prefilled syringes: 5 per sampling point

5.2 Visual Inspection

1. Inspect the seal under adequate lighting for:
   • Proper alignment
   • Absence of crimping or wrinkling
   • No visible leakage or seal gaps
2. Record results in the Sealing Quality Log (Annexure-1).

5.3 Physical Seal Integrity Testing

1. Vials: Perform dye ingress test:
   • Immerse sealed vials in 0.1% methylene blue solution and apply vacuum for 10 minutes.
   • Observe for dye entry; reject any vial with ingress.
2. Ampoules: Conduct flame test:
   • Hold ampoule near flame; observe for leakage via bubbling or flame distortion.
3. Prefilled syringes: Use vacuum chamber method or apply controlled pressure to detect leaks.

5.4 Acceptance Criteria

1. No seal breakage, wrinkles, or misalignment.
2. No leakage, dye ingress, or deformation under pressure.
3. Samples must pass all inspection points; failure in one requires batch hold and investigation.

5.5 Documentation and Control

1. Record test details in Sealing Quality Log (Annexure-1).
2. Report any deviation or failure to QA for disposition.
3. Use the Sealing Defect Report Form (Annexure-2) for non-conformities.
4. Document corrective action taken and submit for QA review.

5.6 Training

1. Operators shall be trained on sealing equipment, defect identification, and test methods.
2. Training records must be maintained as per the training matrix (Annexure-3).

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• GMP: Good Manufacturing Practices
• CCIT: Container Closure Integrity Testing

7. Documents

1. Sealing Quality Log (Annexure-1)
2. Sealing Defect Report Form (Annexure-2)
3. Training Record (Annexure-3)

8. References

• WHO TRS 961 Annex 6 – GMP for Sterile Products
• USP <1207> – Packaging Integrity Evaluation
• ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Sealing Quality Log

Annexure-2: Sealing Defect Report Form

Annexure-3: Training Record

Revision History:

Standard Operating Procedure for Use of Automated Labeling Machines in Packing Lines

1. Purpose

To define the procedure for the use, maintenance, and verification of automated labeling machines used during the packaging of sterile injectable products. This SOP ensures correct label application, traceability, GMP compliance, and minimizes labeling errors.

2. Scope

This SOP applies to all automated labeling machines used in primary and secondary packaging lines of sterile injectable vials and prefilled syringes at the Sterile Injection Manufacturing facility.

3. Responsibilities

• Machine Operator: Responsible for machine setup, operation, minor adjustments, and in-process checks.
• Packaging Supervisor: Ensures compliance with labeling specifications, machine performance, and coordinates with QA for verification.
• QA Personnel: Verifies label placement, batch details, and documents in-process checks.
• Engineering Department: Handles preventive maintenance and breakdown troubleshooting.

4. Accountability

The Head of Production is accountable for ensuring the proper use and maintenance of automated labeling machines as per GMP and company standards.

5. Procedure

5.1 Pre-Operation Checks

1. Verify machine cleanliness and status using the previous batch cleaning log.
2. Ensure labels are approved by QA and match the batch record.
3. Check label roll for batch number, expiry date, product name, and ensure alignment with artwork.
4. Confirm that the reject mechanism is functional and alarm systems are working.
5. Verify camera system settings for code and label verification.

5.2 Label Roll Loading

1. Load the label roll onto the designated spindle as per the machine’s operational manual.
2. Thread the labels through rollers and apply tension as per the manufacturer’s instructions.
3. Ensure label sensors are active and properly calibrated.
4. Record label roll details in the Label Usage Log (Annexure-1).

5.3 Machine Start-Up and Operation

1. Switch ON the labeling machine and allow it to initialize.
2. Feed a few empty containers (vials/syringes) and verify correct label placement and alignment.
3. Perform an initial in-process check on 5 labeled units with QA verification.
4. Start full operation only after receiving QA clearance.
5. Monitor label presence sensors and reject mechanism regularly during the operation.

5.4 In-Process Verification

1. Every 30 minutes or every 1000 units (whichever is earlier), perform a label inspection:
   • Label content accuracy (product name, strength, batch no., expiry).
   • Placement straightness and adhesion quality.
   • Check label camera system logs for rejections or anomalies.
2. Record findings in the In-Process Label Check Record (Annexure-2).

5.5 Handling Deviations

1. Immediately stop the machine if any mislabeling or system fault is observed.
2. Segregate affected units and inform QA.
3. Record the deviation in the Labeling Deviation Log (Annexure-3).

5.6 Machine Shutdown

1. Stop label application and allow the conveyor belt to run until the last unit is labeled.
2. Remove the label roll and store it securely.
3. Clean machine rollers and sensors using lint-free cloth and IPA 70%.
4. Document cleaning in Annexure-4: Machine Cleaning Log.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• IPA: Isopropyl Alcohol
• GMP: Good Manufacturing Practice

7. Documents

1. Label Usage Log – Annexure-1
2. In-Process Label Check Record – Annexure-2
3. Labeling Deviation Log – Annexure-3
4. Machine Cleaning Log – Annexure-4

8. References

• WHO TRS 986 Annex 2 – GMP for Sterile Products
• EU GMP Guide Annex 1 – Manufacture of Sterile Medicinal Products
• 21 CFR Part 211 – Labeling Requirements

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Label Usage Log

Annexure-2: In-Process Label Check Record

Annexure-3: Labeling Deviation Log

Annexure-4: Machine Cleaning Log

Revision History:

Standard Operating Procedure for Final Labeling and Batch Coding of Injectable Vials

1. Purpose

To define the procedure for final labeling and batch coding of injectable vials to ensure traceability, correct product identification, and compliance with GMP and regulatory labeling standards.

2. Scope

This SOP applies to all injectable vials that undergo final labeling and batch coding in the Packaging Department before packing and dispatch.

3. Responsibilities

• Packaging Operators: Perform labeling and batch coding operations as per SOP.
• Packaging Supervisors: Ensure proper setup of machines, verification of printed data, and documentation.
• QA Personnel: Verify label reconciliation, inspect printed output, and ensure compliance with approved batch records.

4. Accountability

The Packaging Head is accountable for implementation of this SOP and ensuring error-free labeling and coding of all injectable vials.

5. Procedure

5.1 Preparation

1. Ensure that the labeling area is clean and labeled as per status.
2. Verify the availability of approved labels from QA.
3. Collect labeling instructions and batch details from the Batch Packaging Record (BPR).
4. Cross-verify the following on labels:
   • Product name
   • Strength and volume
   • Batch number
   • Mfg. and Exp. dates
   • MRP and storage conditions

5.2 Labeling Operation

1. Set up the labeling machine according to vial size and label dimensions.
2. Perform label roll loading, ensuring direction and alignment is correct.
3. Conduct label print trial and get it approved by QA before starting bulk labeling.
4. Operate the machine to label vials with proper adhesion, ensuring:
   • No wrinkles, air bubbles, or misplacement
   • 100% readability and proper orientation

5.3 Batch Coding Operation

1. Set up the coding device (e.g., inkjet, thermal transfer) for batch number, Mfg. and Exp. date printing.
2. Conduct trial printing on dummy labels and get QA approval.
3. Start batch coding process after QA clearance.
4. Inspect printed output for:
   • Clarity and legibility
   • Correct alignment
   • No smudging or faded text
5. Document coding verification in the BPR.

5.4 In-Process Checks

1. Every 30 minutes, verify labeled and coded vials for:
   • Correct batch number and date
   • Defect-free labeling
2. QA to inspect 1% of labeled vials from each lot.

5.5 Reconciliation and Documentation

1. Count and reconcile issued vs. used labels and coded vials.
2. Record unused labels and send them back to QA for destruction.
3. Complete the Label Reconciliation Sheet (Annexure-1).
4. Sign off on batch labeling activity in the BPR.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• BPR: Batch Packaging Record
• MRP: Maximum Retail Price

7. Documents

1. Label Reconciliation Sheet – Annexure-1
2. Batch Coding Verification Log – Annexure-2

8. References

• WHO GMP Guidelines for Packaging
• Schedule M – Drugs and Cosmetics Act

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Label Reconciliation Sheet

Annexure-2: Batch Coding Verification Log

Revision History

Standard Operating Procedure for Visual Inspection of Packed Injectable Products

1. Purpose

To define the procedure for performing visual inspection of packed injectable products to ensure their conformance to approved specifications, freedom from defects, and readiness for batch release and market distribution.

2. Scope

This SOP applies to all packed injectable products (vials, ampoules, and prefilled syringes) post-secondary packaging stage and before storage or dispatch in the Packaging Department.

3. Responsibilities

• Packaging Operators: Conduct visual inspection as per training and guidelines.
• Packaging Supervisors: Monitor compliance and complete inspection documentation.
• QA Officers: Verify inspection results and perform sample rechecks.

4. Accountability

The Head of Packaging is accountable for ensuring that visual inspection is completed and documented for each batch before batch release.

5. Procedure

5.1 Preparation for Inspection

1. Ensure area cleanliness and lighting conditions meet SOP/ENV/114/2024 requirements.
2. Verify that inspectors are qualified and trained for visual inspection tasks.
3. Ensure all products to be inspected are arranged in labeled crates or trays with batch details.

5.2 Visual Inspection Criteria

1. Inspect outer cartons for:
   • Correct batch coding, printing clarity, and label alignment
   • No damage, crushed corners, or soiling
2. Check inner boxes for:
   • Correct leaflet inclusion (if applicable)
   • Seal integrity and tamper-evidence
3. Inspect for:
   • Presence of correct product labeling
   • Uniformity of packing style
   • No misprints or mixed components

5.3 Inspection Methodology

1. Perform 100% visual inspection for critical batches or as per QRM-based sampling plan (Annexure-2).
2. Use the Inspection Log Sheet (Annexure-1) to document inspection results.
3. Flag and segregate defective units in the “Rejected Material Bin.”
4. Defects to look for:
   • Incorrect label, wrong batch number
   • Physical damage or leakage in primary packaging
   • Missing leaflet (if applicable)
   • Illegible or smudged print
5. Instruct QA for re-inspection if rejection rate exceeds control threshold (e.g., 1%).

5.4 Documentation

1. All inspected trays shall be tagged with “Inspected by” slip (signed and dated).
2. Record inspection activity in batch packaging records.
3. Report any deviation to QA using deviation form (SOP/QA/112/2023).

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• QRM: Quality Risk Management

7. Documents

1. Inspection Log Sheet – Annexure-1
2. Sampling Plan for Visual Inspection – Annexure-2

8. References

• ICH Q9: Quality Risk Management
• WHO TRS 986 Annex 2: GMP for Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Inspection Log Sheet

Annexure-2: Sampling Plan for Visual Inspection

Revision History

Standard Operating Procedure for Line Clearance before Packaging Operations

1. Purpose

To define the procedure for performing line clearance prior to the commencement of packing operations, ensuring that the packaging area is free from any remnants of previous batches, products, labels, components, or documents to avoid cross-contamination and mix-ups, in line with GMP and regulatory standards.

2. Scope

This SOP applies to all primary and secondary packaging lines, rooms, and equipment used for the packaging of injectable pharmaceutical products within the Packaging Department.

3. Responsibilities

• Packaging Operator: Conducts physical cleaning and assists in the line clearance process.
• Packaging Supervisor: Ensures the line is properly cleared and documents the clearance.
• Quality Assurance (QA) Officer: Verifies the line clearance and gives authorization to start packaging.

4. Accountability

The Head of Packaging is accountable for implementing and ensuring adherence to this SOP.

5. Procedure

5.1 Pre-Clearance Preparation

1. Ensure completion and closure of all packaging activities for the previous batch.
2. Dispose of all waste materials as per waste handling SOP.
3. Ensure the area is cleaned following the SOP for cleaning of packaging areas.

5.2 Execution of Line Clearance

1. Verify that all packaging components from the previous batch (cartons, leaflets, labels, vials, etc.) are removed.
2. Ensure that no product remnants are left on the packaging equipment or floors.
3. Ensure removal of all batch records, printed material, stickers, and signs related to the previous product.
4. Inspect machines (labeling, blister, cartooning, sealing) for any residual material or documents.
5. Check weighing balance calibration stickers, environmental status display, and room cleaning logs.
6. Fill in the Line Clearance Checklist (Annexure-1) item-wise.

5.3 Verification by QA

1. QA Officer shall physically inspect the entire packaging area and equipment.
2. Cross-verify entries made by the packaging supervisor in the Line Clearance Checklist.
3. Sign the Line Clearance Checklist with date and time to authorize the start of packaging.

5.4 Documentation

1. Maintain the Line Clearance Checklist with the batch packaging records.
2. QA to retain a copy of the signed checklist as per document retention policy.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• GMP: Good Manufacturing Practices

7. Documents

1. Line Clearance Checklist – Annexure-1

8. References

• WHO TRS 961 Annex 6: GMP for Pharmaceutical Products
• ICH Q7: GMP for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Line Clearance Checklist

Revision History